Opening book details…
About this book
Oncolytic Immunotherapy with Nivolumab in Muscle-invasive Bladder Cancer: a Phase 1B Trial by Roger Li & Nancy Y. Villa & Xiaoqing Yu & Joseph O. Johnson & Gustavo Borjas & Jasreman Dhillon & Carlos M. Moran-Segura & Youngchul Kim & Natasha Francis & Denise Dorman & John J. Powers & Wade J. Sexton & Philippe E. Spiess & Michael A. Poch & Logan... is a book available to read on EtoBox.
- Author
- Roger Li & Nancy Y. Villa & Xiaoqing Yu & Joseph O. Johnson & Gustavo Borjas & Jasreman Dhillon & Carlos M. Moran-Segura & Youngchul Kim & Natasha Francis & Denise Dorman & John J. Powers & Wade J. Sexton & Philippe E. Spiess & Michael A. Poch & Logan...
- Publisher
- Springer US
- Published
- 2025
- Language
- EN
More by Roger Li & Nancy Y. Villa & Xiaoqing Yu & Joseph O. Johnson & Gustavo Borjas & Jasreman Dhillon & Carlos M. Moran-Segura & Youngchul Kim & Natasha Francis & Denise Dorman & John J. Powers & Wade J. Sexton & Philippe E. Spiess & Michael A. Poch & Logan...
Similar books
- Oncolytic Adenoviral Therapy Plus Pembrolizumab in BCG-unresponsive Non-muscle-invasive Bladder Cancer: the Phase 2 CORE-001 Trial — Roger Li & Paras H. Shah & Tyler F. Stewart & Jong Kil Nam & Trinity J. Bivalacqua & Donald L. Lamm & Edward M. Uchio & Daniel M. Geynisman & Joseph M. Jacob & Joshua J. Meeks & Rian Dickstein & Shane M. Pearce & Seok Ho Kang & Seung Il Jung & Ashish... (2024)
- Gemcitabine and Cisplatin Plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: a Phase 2 Trial — Matthew D. Galsky & Siamak Daneshmand & Sudeh Izadmehr & Edgar Gonzalez-Kozlova & Kevin G. Chan & Sara Lewis & Bassam El Achkar & Tanya B. Dorff & Jeremy Paul Cetnar & Brock O. Neil & Anishka Damp#x02019; Souza & Ronac Mamtani & Christos Kyriakopoulos &... (2024)
- Sasanlimab Plus BCG in BCG-naive, High-risk Non-muscle Invasive Bladder Cancer: the Randomized Phase 3 CREST Trial — Neal D. Shore & Thomas B. Powles & Jens Bedke & Matthew D. Galsky & Joan Palou Redorta & Ja Hyeon Ku & Michal Kretkowski & Evanguelos Xylinas & Boris Alekseev & Dingwei Ye & Félix Guerrero-Ramos & Alberto Briganti & Girish S. Kulkarni & Julia Brinkmann... (2025)
- Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Early-stage Triple-negative Breast Cancer: a Phase 2 Adaptive Trial — Iris Nederlof & Olga I. Isaeva & Manon Graaf & Robbert C. A. M. Gielen & Noor A. M. Bakker & Adrianne L. Rolfes & Hannah Garner & Bram Boeckx & Joleen J. H. Traets & Ingrid A. M. Mandjes & Michiel Maaker & Thomas Brussel & Maksim Chelushkin & Elisa... (2024)
- High- or Low-dose Preoperative Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer: the Phase 1B NABUCCO Trial — Jeroen Dorp & Christodoulos Pipinikas & Britt B. M. Suelmann & Niven Mehra & Nick Dijk & Giovanni Marsico & Maurits L. Montfoort & Sophie Hackinger & Linde M. Braaf & Tauanne Amarante & Charlaine Steenis & Kirsten McLay & Antonios Daletzakis & Daan... (2023)
- Nivolumab Plus Ipilimumab in Advanced Salivary Gland Cancer: a Phase 2 Trial — Joris L. Vos & Bharat Burman & Swati Jain & Conall W. R. Fitzgerald & Eric J. Sherman & Lara A. Dunn & James V. Fetten & Loren S. Michel & Anuja Kriplani & Kenneth K. Ng & Juliana Eng & Vatche Tchekmedyian & Sofia Haque & Nora Katabi & Fengshen Kuo &... (2023)